acamprosate calcium

FDA Drug Profile — acamprosate calcium

acamprosate calcium is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including acamprosate calcium. Available dosage form: tablet, delayed release.

Drug details

Generic Name
acamprosate calcium
Brand Names
acamprosate calcium
Application Number
ANDA205995
Sponsor
REMEDYREPACK INC.
NDC Codes
3
Dosage Forms
TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients
ACAMPROSATE CALCIUM

Indications and Usage

1 INDICATIONS AND USAGE Acamprosate calcium is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium should be part of a comprehensive management program that includes psychosocial support. The efficacy of acamprosate calcium in promoting abstinence has not been demonstrated in subjects who have not undergone detoxification and not achieved alcohol abstinence prior to beginning acamprosate calcium treatment. The efficacy of acamprosate calcium in promoting abstinence from alcohol in polysubstance abusers has not been adequately assessed. Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation (1, 14). Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support (1).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.